Global Vascular Graft Market Size to Reach USD 7.74 Billion 2032 | Emergen Research

Increasing aging population and rising prevalence of aneurysm are key factors driving market revenue growth

Vancouver, Aug. 24, 2023 (GLOBE NEWSWIRE) — The anticipated trajectory of the global vascular graft market points towards reaching a substantial valuation of USD 7.74 Billion by the year 2032. This projection is underpinned by a consistent and gradual Compound Annual Growth Rate (CAGR) of 7.3% throughout the forecast period, as evidenced by the latest analysis conducted by Emergen Research.

One of the primary drivers behind this upward trend is the escalating prevalence of Cardiovascular Diseases (CVD). This notable health concern underscores the importance of vascular grafts as a pivotal element in the healthcare landscape. Afflictions like Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD), and aneurysms, which are encompassed within the spectrum of CVD, necessitate the intervention of vascular graft surgeries. The widespread occurrence of these diseases globally has underscored the imperative for efficacious therapeutic interventions, thus propelling the demand for vascular grafts. These grafts play a pivotal role in critical medical procedures, such as bypass surgery or arterial repair/replacement, especially among the elderly patient demographic.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2059

The robust expansion of the vascular graft market can be attributed to the proactive engagement of healthcare professionals who are earnestly addressing the mounting requisites for cardiovascular treatments. Furthermore, the landscape is being invigorated by transformative technological advancements that bolster the safety, efficacy, and longevity of vascular grafts. Innovations in the form of biocompatible materials, refined graft designs, and minimally invasive surgical methodologies collectively contribute to enhancing the overall market dynamics. This concerted push toward innovation not only augments patient outcomes but also fuels the economic growth of the market.

It’s important to acknowledge that there exist factors that could potentially impede the otherwise promising trajectory of revenue growth in the vascular graft market. One such factor is the occurrence of product failures and subsequent recalls. In-depth analysis conducted by Gore revealed that these mislabeling scenarios held the potential to lead to adverse consequences for patients. The paramount commitment of Gore to uphold the utmost quality standards drove the decision to conduct this recall. This proactive approach underscores the significance of patient safety and aligns with the industry’s endeavor to ensure the efficacy and reliability of medical products. Instances such as these emphasize the pivotal role of stringent quality control measures and post-market surveillance in maintaining the integrity of the vascular graft market. While challenges such as product recalls can pose obstacles, they also serve as catalysts for reinforcing a culture of safety and continual improvement within the industry.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2059

Scope of Research

Major Companies and Competitive Landscape

The global vascular graft market is fragmented, with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective vascular graft services. Some major players included in the global vascular graft market report are:

• B. Braun SE
• BD
• Cook
• Cordis
• ENDOLOGIX LLC
• Getinge
• LeMaitre Vascular, Inc.
• Medtronic plc
• Terumo Medical Corporation
• W. L. Gore & Associates, Inc.

Strategic Development

• On 26 May 2022, a USD 3 million CIRM grant was awarded to UC Davis to create a smart vascular graft ffor renal patients. This apparatus employs a special chemical that directs the body’s own stem cells in an effort to reduce the failure rate of artificial vascular grafts. Patients receiving hemodialysis for renal illness frequently experience such failures.
• On 6 January 2020, Kipsbay Medical Inc., which is an innovator in the fields of venous external stenting and vascular engineering, produced and controlled a number of patent families that Vascular Graft Solutions (VGS) acquired from NEOGRAFT Technologies Inc.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2059

Some Key Highlights From the Report

• The polyester grafts segment is expected to account for largest revenue share during the forecast period. Increasing prevalence of cardiovascular diseases and rising demand for vascular bypass procedures have both had positive impact on increasing use of polyester grafts. These grafts are a well-liked alternative due to their favorable traits and affordability, which is driving revenue growth of the segment.
• The endovascular aneurysm repair segment is expected to account for largest revenue share during the forecast period. Vascular grafts serve as the stent grafts that sustain the aneurysm’s structure and seal it off, making them crucial to endovascular aneurysm repair procedures. Increasing preference for endovascular aneurysm repair as a method of treating abdominal aortic aneurysms is driving revenue growth of the segment.
• The market in North America is expected to account for largest revenue share during the forecast period. Vascular grafts use has increased as a result of the developed healthcare system and significant emphasis on innovative medical technologies in North America. In addition, the favorable insurance and payment policies in the region promote the use of vascular grafts in surgical procedures.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/vascular-graft-market

Emergen Research has segmented the global vascular graft market on the basis of raw material, indication, end-use, region:

• Raw Material Outlook (Revenue, USD Billion; 2019–2032)                                           

• • Polyester Grafts
  • ePTFE
  • Polyurethane Grafts
  • Biosynthetic Grafts

• Indication Outlook (Revenue, USD Billion; 2019–2032)                                           

• • Endovascular Aneurysm Repair
    1. Abdominal Aortic Aneurysms Repair
    2. Thoracic Aortic Aneurysm Repair
  • Peripheral Vascular
  • Hemodialysis Access

• End-use Outlook (Revenue, USD Billion; 2019–2032)                                           

• • Hospitals
  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million; 2019–2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. U.K.
    3. France
    4. Italy
    5. Spain
    6. Sweden
    7. BENELUX
    8. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. U.A.E.
    3. South Africa
    4. Israel
    5. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Functional Ingredients Market By Product (Probiotics, Maltodextrin, Polydextrose, Pectin, Modified Starch, and Others), By Source (Natural, Synthetic), By Application (Pharmaceuticals, Food & Beverages, Animal Feed, Personal Care, Others), and By Region Forecast to 2028

Emulsifiers Market By Product Type (Bio-Based, Synthetic), By Distribution Channel (Direct, Indirect), By Industry Vertical (Food & Beverage, Oil & Gas, Cosmetics & Personal Care, Agrochemical, Pharmaceutical, Paints & Coatings), and By Region Forecast to 2028

Personalized Therapy Biosimulation Market By Product (Software, Services), By Therapeutic Area (Oncology, Others), By Application (Drug Development, Drug discovery, Others), By End-Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others), By Region Forecast to 2028

Nutrigenomics Market By Application (Cardiovascular Diseases, Cancer Research, Obesity, Diabetes), By Product (Reagents and Kits, Services), and By Region Forecast to 2028

Sanger Sequencing Services Market by Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others), by End Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics), and By Region Forecast to 2028

Whole Exome Sequencing Market, By Product Type (Systems, Kits, and Service), By Technology (Sequencing by Synthesis and Ion Semiconductor Sequencing), By Application, By End-use, and By Region Forecast to 2030

Health Data Archiving Market Size, Share, Trends, By Type (Flash & Solid-State Storage, Magnetic Storage), By Storage System (Direct-Attached Storage, Storage Area Network, Network-Attached Storage), By Deployment, By Architecture, By End-use, and By Region Forecast to 2028

Gel Documentation System Market By Product Type (Instruments, Software, Accessories), By Light Source (Light-Emitting Diodes, UV, Laser), By Detection Technique (UV Detectors, Fluorescence, Chemiluminescence), By Application (Nucleic Acid Quantification, Protein Quantification, Other Applications), By End-Use (Academic & Research Institutes, Pharma & Biotech Companies, Diagnostic Laboratories), and By Region Forecast to 2028

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Vascular Graft Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-vascular-graft-market